CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
Crossref DOI link: https://doi.org/10.1007/s11904-018-0375-2
Published Online: 2018-01-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Calcagno, Andrea
Barco, Ambra
Trunfio, Mattia
Bonora, Stefano
Funding for this research was provided by:
Gilead Sciences
Bristol-Myers Squibb Foundation
ViiV Healthcare
License valid from 2018-01-23